- 全部删除
您的购物车当前为空
AZ 12799734 是一种具有口服活性、选择性和有效性的 TGFBR1和 ALK5 双重抑制剂,对 BMP 和 TGFβ 有抑制作用,可用于研究肿瘤。


为众多的药物研发团队赋能,
让新药发现更简单!
AZ 12799734 是一种具有口服活性、选择性和有效性的 TGFBR1和 ALK5 双重抑制剂,对 BMP 和 TGFβ 有抑制作用,可用于研究肿瘤。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 378 | In stock | |
| 5 mg | ¥ 953 | In stock | |
| 10 mg | ¥ 1,490 | In stock | |
| 25 mg | ¥ 2,970 | In stock | |
| 50 mg | ¥ 4,860 | In stock | |
| 100 mg | ¥ 6,730 | In stock | |
| 200 mg | ¥ 8,910 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 987 | In stock |
AZ 12799734 相关产品
| 产品描述 | AZ 12799734 is an orally active, selective and potent dual inhibitor of TGFBR1 and ALK5 with inhibitory effects on BMP and TGFβ for the study of tumours. |
| 靶点活性 | TGFβRI:47 nM, ALK5:0.74 μM (Kd), ALK6:0.017 μM (Kd), ACVR1:6.2 μM (Kd), BMPR1A:40 μM (Kd), ALK1:7.1 μM (Kd), ALK4:1 μM (Kd) |
| 体外活性 | Inhibiting ligand-activated SMAD3/4 transcription, AZ12799734[2]. |
| 体内活性 | Inducing histopathologic heart valve lesions in rats, AZ12799734 is administered orally at doses ranging from 0 to 400 mg/kg/day for 3-7 days[1]. |
| 别名 | AZ12799734 |
| 分子量 | 370.43 |
| 分子式 | C18H18N4O3S |
| CAS No. | 1117684-36-2 |
| Smiles | O(C=1C=C(NC2=CC=C(S(N)(=O)=O)C=C2)N=CC1)C3=C(C)N=C(C)C=C3 |
| 存储 | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 80 mg/mL (215.97 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容